Medicared For All Logo

Amaryllis Gil MD in Elmhurst, Illinois

Home Illinois Elmhurst

Amaryllis Gil MD has Hematology/oncology as her primary medical specialty. Their primary office is: 177 E Brush Hill Rd in Elmhurst, Illinois.

They're a part of the: Edward Health Ventures medical group which has around 519 members. You can call their office at 331-221-5900 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Loyola University Of Chicago, Stritch School Of Medicine and graduated in 1994 (around 30 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Amaryllis Gil MD Office Phone and Directions

Amaryllis Gil MD
Edward Health Ventures
177 E Brush Hill Rd
Elmhurst, Illinois 60126
331-221-5900


Patient Ratings
Please rate your experience with Amaryllis Gil MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 331-221-5900


Enter a starting address:


Healthcare Info for Amaryllis Gil MD

Additional Medical Specialties Include:
HOSPICE/PALLIATIVE CARE, INTERNAL MEDICINE

Medical School: Loyola University Of Chicago, Stritch School Of Medicine
Graduation Year: 1994
The Primary Medical Specialty for Amaryllis Gil MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 30
PAC (PECOS ID)#: 1254301435
NPI #: 1235116591
NPI Created On: 12/28/2005
NPI Last Updated Listed as: 09/18/2013
Primary Taxonomy Code: 207RH0003X
License Number:
36104085
Listed Gender: Female

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Celtic Insurance Company
  • Blue Cross Blue Shield
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Hindi, Spanish.


Services and Procedures include:

  1. New patient office or other outpatient visit, typically 30 minutes
  2. New patient office or other outpatient visit, typically 45 minutes
  3. New patient office or other outpatient visit, typically 60 minutes
  4. Established patient office or other outpatient visit, typically 15 minutes
  5. Established patient office or other outpatient, visit typically 25 minutes
  6. Established patient office or other outpatient, visit typically 40 minutes
  7. Initial hospital inpatient care, typically 70 minutes per day
  8. Subsequent hospital inpatient care, typically 25 minutes per day
  9. Subsequent hospital inpatient care, typically 35 minutes per day
  10. Physician telephone patient service, 5-10 minutes of medical discussion
  11. Physician telephone patient service, 11-20 minutes of medical discussion

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835887101

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: BioOncology

Name of Drug #1: Kadcyla

Open Associated Drug #1: 50242-087-01

Drug or Biological: Biological

Product Category #2: BioOncology

Name Of Drug #2:: Phesgo

Associated Drug #2: 50242-245-01


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835887103

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: BioOncology

Name of Drug #1: Kadcyla

Open Associated Drug #1: 50242-087-01

Drug or Biological: Biological

Product Category #2: BioOncology

Name Of Drug #2:: TECENTRIQ

Associated Drug #2: 50242-917-01

Drug or Biological #3:: Biological

Product Category #3: BioOncology

Name of Drug: Phesgo

Name Of Drug #3: 50242-245-01


Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835887105

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: BioOncology

Name of Drug #1: Kadcyla

Open Associated Drug #1: 50242-087-01

Drug or Biological: Biological

Product Category #2: BioOncology

Name Of Drug #2:: TECENTRIQ

Associated Drug #2: 50242-917-01

Drug or Biological #3:: Biological

Product Category #3: BioOncology

Name of Drug: Phesgo

Name Of Drug #3: 50242-245-01


Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835887107

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: BioOncology

Name of Drug #1: Kadcyla

Open Associated Drug #1: 50242-087-01

Drug or Biological: Biological

Product Category #2: BioOncology

Name Of Drug #2:: TECENTRIQ

Associated Drug #2: 50242-917-01

Drug or Biological #3:: Biological

Product Category #3: BioOncology

Name of Drug: Phesgo

Name Of Drug #3: 50242-245-01


Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 835339537

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: SICKLE CELL DISEASE

Name of Drug #1: OXBRYTA

Open Associated Drug #1: 72786-101-01


Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Context of payment:: ;G2783731;EPRINTS;10770919

Record ID:: 845873353

Being Disputed:: No

Product Related: Yes


Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 851043573

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: Xermelo

Open Associated Drug #1: 70183-125-85


Hematology/oncology Professionals in Elmhurst

177 E Brush Hill Rd
Elmhurst, IL
Edward Health Ventures

177 E Brush Hill Rd
Elmhurst, IL
Edward Health Ventures

177 E Brush Hill Rd
Elmhurst, IL
Edward Health Ventures

200 Berteau Ave
Elmhurst, IL
University Of Chicago

200 Berteau Ave
Elmhurst, IL
University Of Chicago

155 E Brush Hill Rd
Elmhurst, IL
Edward Health Ventures

Providers in Edward Health Ventures

1.Jon Aagaard

1200 S York St
Elmhurst Il 60126-5632
Edward Health Ventures
Family Practice

2.Ramez Abdalla

120 Spalding Dr
Naperville Il 60540-6599
Edward Health Ventures
Diagnostic Radiology

3.Ramez Abdalla

801 S Washington St
Naperville Il 60540-7430
Edward Health Ventures
Diagnostic Radiology

4.Mary Adams

303 W Lake St
Addison Il 60101-2565
Edward Health Ventures
Nurse Practitioner

5.Mary Adams

6701 Us Hwy 34
Oswego Il 60543-9129
Edward Health Ventures
Nurse Practitioner

6.George Aghia

2007 95th St
Naperville Il 60564-7802
Edward Health Ventures
Family Practice

View all 519 members of Edward Health Ventures medical group